Almost 90% of Americans support direct U.S. government negotiations on COVID-19 treatment.
The intersection between the COVID-19 pandemic and the rising cost of healthcare has created wide-ranging ramifications for Americans. Nearly nine in 10 U.S. adults are "very" (55%) or "somewhat" (33%) concerned that the pharmaceutical industry will leverage the COVID-19 pandemic to raise drug prices.
Amid such concerns on how the COVID-19 pandemic could cause a rise in prices for drugs, insurance and healthcare, a large majority of Americans support direct negotiations by the federal government with drug manufacturers on the price of treatments for the disease. Nearly nine in 10 (88%) respondents in a new study by West Health and Gallup support such an approach.
There are little differences based on political identity.